Bilirubin measurement
|
phenotype |
|
Laboratory Procedure
|
56
|
535
|
0.100 |
None |
1.000 |
13 |
228
|
2009 |
2019 |
Crigler Najjar syndrome, type 1
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
17
|
38
|
0.180 |
None |
1.000 |
11 |
38
|
1994 |
2015 |
Bilirubin level result
|
phenotype |
|
Laboratory or Test Result
|
32
|
478
|
0.100 |
None |
1.000 |
6 |
217
|
2009 |
2013 |
Cholelithiasis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
252
|
90
|
0.140 |
None |
0.800 |
5 |
5
|
2001 |
2012 |
Hyperbilirubinemia
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
131
|
27
|
0.050 |
None |
1.000 |
5 |
7
|
1998 |
2016 |
Gilbert Disease (disorder)
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
40
|
29
|
0.150 |
None |
1.000 |
5 |
21
|
2001 |
2010 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.040 |
None |
1.000 |
4 |
4
|
2007 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.040 |
None |
1.000 |
4 |
4
|
2007 |
2019 |
Liver carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5725
|
942
|
0.040 |
None |
1.000 |
4 |
3
|
1997 |
2019 |
Serum total cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
486
|
1243
|
0.100 |
None |
1.000 |
3 |
2
|
2012 |
2018 |
Low density lipoprotein cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
483
|
1142
|
0.100 |
None |
1.000 |
3 |
2
|
2013 |
2018 |
Hyperbilirubinemia, Neonatal
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Disease or Syndrome
|
33
|
15
|
0.030 |
None |
1.000 |
3 |
5
|
2012 |
2017 |
Cholecystolithiasis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
156
|
62
|
0.030 |
None |
0.667 |
3 |
3
|
2001 |
2003 |
Blood Protein Measurement
|
phenotype |
|
Laboratory Procedure
|
1156
|
2575
|
0.100 |
None |
1.000 |
2 |
4
|
2018 |
2018 |
Leukopenia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
440
|
153
|
0.020 |
None |
1.000 |
2 |
2
|
2015 |
2015 |
Seizures
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
2152
|
553
|
0.020 |
None |
1.000 |
2 |
1
|
2010 |
2017 |
Icterus
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
241
|
17
|
0.020 |
None |
1.000 |
2 |
1
|
2008 |
2010 |
Neutropenia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
389
|
97
|
0.020 |
None |
1.000 |
2 |
2
|
2015 |
2015 |
Familial (FPAH)
|
disease |
|
Disease or Syndrome
|
1075
|
276
|
0.020 |
None |
1.000 |
2 |
|
1992 |
1997 |
Unconjugated hyperbilirubinemia
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
23
|
4
|
0.020 |
None |
1.000 |
2 |
2
|
1997 |
2002 |
Serum albumin measurement
|
phenotype |
|
Laboratory Procedure
|
433
|
3282
|
0.100 |
None |
1.000 |
2 |
88
|
2013 |
2014 |
Secondary malignant neoplasm of colon and/or rectum
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
397
|
68
|
0.020 |
None |
1.000 |
2 |
3
|
2014 |
2015 |
Drug-Induced Liver Disease
|
phenotype |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
537
|
29
|
0.310 |
None |
1.000 |
2 |
2
|
2011 |
2015 |
Metabolic Syndrome X
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
1125
|
591
|
0.110 |
None |
1.000 |
2 |
5
|
2008 |
2019 |
Diarrhea
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
632
|
63
|
0.020 |
None |
1.000 |
2 |
1
|
2010 |
2012 |